Stockholders' Equity (Details Textual) - USD ($) |
1 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Aug. 31, 2017 |
Jun. 15, 2017 |
Jan. 31, 2017 |
Jan. 31, 2016 |
Jan. 31, 2015 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Stockholders' Equity (Textual) | |||||||
| Authorized to issue and sale, shares | 80,000,000 | 80,000,000 | |||||
| Common stock, shares authorized | 75,000,000 | 75,000,000 | |||||
| Common stock, par value | $ 0.001 | $ 0.001 | |||||
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | |||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | |||||
| Preferred stock, outstanding | |||||||
| Recognized options and warrants vest over period | 5 years | ||||||
| Options exercised | 249,309 | ||||||
| Proceeds from exercise options | $ 129,255 | $ 2,600 | |||||
| Stock-based compensation | $ 1,633,485 | $ 735,429 | |||||
| Warrant exercise price per share | $ 5.30 | ||||||
| Stock units issued value | $ 5,157,080 | ||||||
| Consultants Two [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Number of options granted | 85,000 | ||||||
| Performance based and continuous service vesting, description | The stock options have an exercise price of $2.02 per share and are exercisable during a ten-year term, are subject to vesting over periods of three and four years and have an aggregate measurement date fair value of $269,416. | ||||||
| Recognized options and warrants vest over period | 4 years | ||||||
| Exercise price of stock option | $ 2.02 | ||||||
| Stock option aggregate grant fair value | $ 269,416 | ||||||
| Weighted average remaining contractual life, warrant | 5 years | ||||||
| Stock units shares sold | 180,000 | ||||||
| Share price | $ 1.99 | ||||||
| Stock Options [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Number of shares issue and outstanding, percentage | 20.00% | ||||||
| Warrants issued to purchase common stock | 180,000 | ||||||
| Number of options granted | 1,031,000 | ||||||
| Performance based and continuous service vesting, description |
The Company granted stock options to employees to purchase 1,031,000 shares of the Company’s common stock at an exercise price of $2.40 per share. The options have terms of ten years. Of the 1,031,000 stock options granted, 300,000 are subject to vesting based on continuous service over periods between zero and four years from the date of grant. The balance of the grant, or 731,000 shares, has performance-based vesting conditions and will be valued at the time the milestones are reached. The stock options have an aggregate grant date fair value of $528,580.
|
During the year ended December 31, 2016, the Company granted stock options to employees to purchase 1,696,000 shares of the Company's common stock. The stock options have exercise prices that range from $1.10 to $1.55 per share, are subject to vesting over four years, have terms of ten years and have an aggregate grant date fair value of approximately $1,418,000. | |||||
| Number of shares vesting | 300,000 | ||||||
| Recognized options and warrants vest over period | 4 years | ||||||
| Exercise price of stock option | $ 2.40 | ||||||
| Stock option aggregate grant fair value | $ 528,580 | ||||||
| Options exercised | 123,333 | 10,000 | |||||
| Number of options cancelled | 153,750 | 26,486 | |||||
| Options expired | Jul. 06, 2016 | ||||||
| Stock Options [Member] | Officers and Directors [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Number of options granted | 200,000 | ||||||
| Performance based and continuous service vesting, description | The stock options have an exercise price of $4.60 per share and are exercisable during a ten-year term, are subject to vesting over four years and have an aggregate grant date fair value of $719,360. | ||||||
| Recognized options and warrants vest over period | 4 years | ||||||
| Stock option aggregate grant fair value | $ 719,360 | ||||||
| Compensation Options [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Aggregate shares of common stock | 731,100 | ||||||
| Options exercised | 731,100 | ||||||
| Number of options granted to agents | 786,696 | ||||||
| Cash proceeds from warrants | $ 731,100 | ||||||
| Option granted exercise price | $ 1.00 | ||||||
| Description of warrants | Each whole warrant issuable upon exercise of Compensation Options is exercisable to acquire one share of common stock at an exercise price of $2.00 per share at any time up to January 6, 2017. Because the Compensation Options are considered a cost of the IPO, the resulting value is recognized as both an increase and decrease to the equity section of the accompanying balance sheets. The Compensation Options are not part of the Company's 2011 Plan. | ||||||
| Warrant [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Warrants issued to purchase common stock | 125,000 | 365,550 | |||||
| Number of options granted | 3,618,053 | 490,550 | |||||
| Performance based and continuous service vesting, description | The Company's common stock to an investor relations firm as partial compensation for consulting services to be provided over a two-year period. The warrant is exercisable at $1.15 per share, has a term of three years and is subject to vesting over the two-year service period. | ||||||
| Options exercised | (1,070,238) | (1,745,890) | |||||
| Number of options cancelled | 4,695,846 | ||||||
| Number of warrants exercised | 926,588 | 143,650 | |||||
| Cash proceeds from warrants | $ 1,853,176 | $ 111,994 | $ 2,969,454 | ||||
| Additional proceeds amount | $ 522,326 | ||||||
| Number of warrants expired | 4,695,846 | ||||||
| Warrant exercised | 1,745,890 | ||||||
| Warrant exercise price per share | $ 1.15 | ||||||
| Aggregate intrinsic value | $ 14,280,372 | ||||||
| 2011 Plan [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Number of shares issue and outstanding, percentage | 20.00% | 20.00% | |||||
| Remaining options to be issued | 1,041,793 | ||||||
| Increase number of shares authorized and issuance | 7,171,540 | ||||||
| Warrants issued to purchase common stock | 125,000 | ||||||
| Employees [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Stock option granted to employee | 280,000 | ||||||
| Options exercised | 123,333 | 10,000 | |||||
| Private Offering [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Proceeds from issuance, net | $ 5,020,000 | ||||||
| Private Offering [Member] | Officers and Directors [Member] | |||||||
| Stockholders' Equity (Textual) | |||||||
| Warrants issued to purchase common stock | 3,438,053 | ||||||
| Exercise price of stock option | $ 4.60 | ||||||
| Warrant exercise price per share | $ 1.50 | ||||||
| Stock units shares sold | 289,334 | ||||||
| Description of warrants | Each warrant can be exercised at any time prior to June 30, 2020 for the purchase of one share of the Company's common stock at an exercise price of $2.25. | ||||||